{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T18:05:01Z","timestamp":1773252301684,"version":"3.50.1"},"reference-count":93,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.heliyon.2024.e35953","type":"journal-article","created":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T02:26:36Z","timestamp":1723256796000},"page":"e35953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A systematic review and meta-analysis of ischemia-modified albumin in diabetes mellitus"],"prefix":"10.1016","volume":"10","author":[{"given":"Angelo","family":"Zinellu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8699-1412","authenticated-orcid":false,"given":"Arduino A.","family":"Mangoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.heliyon.2024.e35953_bib1","article-title":"Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025","volume":"10","author":"Lin","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35953_bib2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","article-title":"Epidemiology of type 2 diabetes - global burden of disease and forecasted trends","volume":"10","author":"Khan","year":"2020","journal-title":"J Epidemiol Glob Health"},{"issue":"10397","key":"10.1016\/j.heliyon.2024.e35953_bib3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","author":"Collaborators","year":"2023","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e35953_bib4","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S2213-8587(22)00257-1","article-title":"Growing global burden of type 1 diabetes needs multitiered precision public health interventions","volume":"10","author":"Guo","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e35953_bib5","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S2213-8587(22)00218-2","article-title":"Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study","volume":"10","author":"Gregory","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35953_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12884-022-04420-9","article-title":"Trends in percentages of gestational diabetes mellitus attributable to overweight, obesity, and morbid obesity in regional Victoria: an eight-year population-based panel study","volume":"22","author":"Mnatzaganian","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35953_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12884-022-04389-5","article-title":"Burden, risk factors and outcomes associated with gestational diabetes in a population-based cohort of pregnant women from North India","volume":"22","author":"Bahl","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"issue":"24","key":"10.1016\/j.heliyon.2024.e35953_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17249387","article-title":"A review of the current status of gestational diabetes mellitus in Australia-the clinical impact of changing population demographics and diagnostic criteria on prevalence","volume":"17","author":"Laurie","year":"2020","journal-title":"Int J Environ Res Public Health"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e35953_bib9","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2337\/dc22-2376","article-title":"Global prevalence of prediabetes","volume":"46","author":"Rooney","year":"2023","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e35953_bib10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11892-018-1089-y","article-title":"Issues in defining the burden of prediabetes globally","volume":"18","author":"Echouffo-Tcheugui","year":"2018","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.heliyon.2024.e35953_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40842-019-0080-0","article-title":"Global epidemiology of prediabetes - present and future perspectives","volume":"5","author":"Hostalek","year":"2019","journal-title":"Clin Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35953_bib12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12916-019-1281-1","article-title":"Advances in the clinical management of type 2 diabetes: a brief history of the past 15 years and challenges for the future","volume":"17","author":"Sattar","year":"2019","journal-title":"BMC Med."},{"issue":"17","key":"10.1016\/j.heliyon.2024.e35953_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713381","article-title":"Advances in research on type 2 diabetes mellitus targets and therapeutic agents","volume":"24","author":"Su","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e35953_bib14","doi-asserted-by":"crossref","first-page":"689","DOI":"10.4239\/wjd.v5.i5.689","article-title":"Advances in management of type 1 diabetes mellitus","volume":"5","author":"Aathira","year":"2014","journal-title":"World J. Diabetes"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35953_bib15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12967-021-02778-6","article-title":"Diagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era","volume":"19","author":"Akil","year":"2021","journal-title":"J. Transl. Med."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e35953_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10102202","article-title":"Recent advances in gestational diabetes mellitus","volume":"10","author":"Benhalima","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.heliyon.2024.e35953_bib17","article-title":"Research advances in gestational, neonatal diabetes mellitus and metabolic disorders","volume":"13","author":"Bukhari","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"14","key":"10.1016\/j.heliyon.2024.e35953_bib18","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1001\/jama.2023.4063","article-title":"Diagnosis and management of prediabetes: a review","volume":"329","author":"Echouffo-Tcheugui","year":"2023","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e35953_bib19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.trsl.2012.01.009","article-title":"Biomarkers in diabetes: hemoglobin A1c, vascular and tissue markers","volume":"159","author":"Lyons","year":"2012","journal-title":"Transl. Res."},{"key":"10.1016\/j.heliyon.2024.e35953_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4137\/BMI.S38440","article-title":"Significance of HbA1c test in diagnosis and prognosis of diabetic patients","volume":"11","author":"Sherwani","year":"2016","journal-title":"Biomark. Insights"},{"key":"10.1016\/j.heliyon.2024.e35953_bib21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejogrb.2023.11.007","article-title":"Influence of gestational diabetes mellitus on subclinical myocardial dysfunction during pregnancy: a systematic review and meta-analysis","volume":"292","author":"Sonaglioni","year":"2024","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.heliyon.2024.e35953_bib22","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2147\/DMSO.S100074","article-title":"Novel biomarkers for prediabetes, diabetes, and associated complications","volume":"10","author":"Dorcely","year":"2017","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e35953_bib23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11892-022-01453-4","article-title":"Recent developments in biomarkers for diagnosis and screening of type 2 diabetes mellitus","volume":"22","author":"Ortiz-Martinez","year":"2022","journal-title":"Curr Diab Rep"},{"issue":"Suppl","key":"10.1016\/j.heliyon.2024.e35953_bib24","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1016\/j.molmet.2019.06.016","article-title":"Biomarkers for type 2 diabetes","volume":"27S","author":"Laakso","year":"2019","journal-title":"Mol Metab"},{"key":"10.1016\/j.heliyon.2024.e35953_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9945424","article-title":"Ischemia-modified albumin: origins and clinical implications","volume":"2021","author":"Shevtsova","year":"2021","journal-title":"Dis. Markers"},{"issue":"2\u20133","key":"10.1016\/j.heliyon.2024.e35953_bib26","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000097644","article-title":"Ischemia-modified albumin in acute stroke","volume":"23","author":"Abboud","year":"2007","journal-title":"Cerebrovasc. Dis."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e35953_bib27","article-title":"A comparative study of ischemia-modified albumin: a promising biomarker for early detection of acute coronary syndrome (ACS)","volume":"15","author":"Jawade","year":"2023","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e35953_bib28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2133\/dmpk.24.333","article-title":"Ischemia modified albumin: a novel biomarker for the detection of cardiac ischemia","volume":"24","author":"Gaze","year":"2009","journal-title":"Drug Metab Pharmacokinet"},{"issue":"13","key":"10.1016\/j.heliyon.2024.e35953_bib29","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1503\/cmaj.045194","article-title":"Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome","volume":"172","author":"Worster","year":"2005","journal-title":"CMAJ (Can. Med. Assoc. J.)"},{"key":"10.1016\/j.heliyon.2024.e35953_bib30","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.biopha.2018.09.058","article-title":"Molecular pathways associated with oxidative stress in diabetes mellitus","volume":"108","author":"Ighodaro","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e35953_bib31","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s11684-019-0729-1","article-title":"Oxidative stress and diabetes: antioxidative strategies","volume":"14","author":"Zhang","year":"2020","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35953_bib32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s12933-023-01965-7","article-title":"The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction","volume":"22","author":"An","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e35953_bib33","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s11154-023-09816-2","article-title":"Hidden chronic metabolic acidosis of diabetes type 2 (CMAD): clues, causes and consequences","volume":"24","author":"Giha","year":"2023","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e35953_bib34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1089\/met.2010.0108","article-title":"Metabolic acidosis-induced insulin resistance and cardiovascular risk","volume":"9","author":"Souto","year":"2011","journal-title":"Metab. Syndr. Relat. Disord."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35953_bib35","doi-asserted-by":"crossref","DOI":"10.2174\/1573399817666210309104203","article-title":"Diabetic complications: an update on pathobiology and therapeutic strategies","volume":"18","author":"Nellaiappan","year":"2022","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.heliyon.2024.e35953_bib36","series-title":"Joanna Briggs Institute Reviewer's Manual","article-title":"Systematic reviews of etiology and risk","author":"Moola","year":"2017"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e35953_bib37","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.heliyon.2024.e35953_bib38","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.heliyon.2024.e35953_bib39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e35953_bib40","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"issue":"7414","key":"10.1016\/j.heliyon.2024.e35953_bib41","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.heliyon.2024.e35953_bib42","first-page":"15","article-title":"Assessing the influence of a single study in the meta-analysis estimate","volume":"47","author":"Tobias","year":"1999","journal-title":"Stata Technical Bulletin"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e35953_bib43","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e35953_bib44","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0895-4356(01)00377-8","article-title":"Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis","volume":"54","author":"Sterne","year":"2001","journal-title":"J. Clin. Epidemiol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e35953_bib45","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e35953_bib46","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1155\/2008\/784313","article-title":"Ischemia-modified albumin level in type 2 diabetes mellitus - preliminary report","volume":"24","author":"Piwowar","year":"2008","journal-title":"Dis. Markers"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e35953_bib47","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s12020-009-9236-5","article-title":"A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin","volume":"36","author":"Ukinc","year":"2009","journal-title":"Endocrine"},{"issue":"5\u20136","key":"10.1016\/j.heliyon.2024.e35953_bib48","first-page":"187","article-title":"Type 2 diabetes mellitus without vascular complications and ischemia modified albumin","volume":"56","author":"Dahiya","year":"2010","journal-title":"Clin. Lab."},{"issue":"4\u20135","key":"10.1016\/j.heliyon.2024.e35953_bib49","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.clinbiochem.2009.11.018","article-title":"Association between ischemia modified albumin, inflammation and hyperglycemia in type 2 diabetes mellitus","volume":"43","author":"Kaefer","year":"2010","journal-title":"Clin. Biochem."},{"issue":"16","key":"10.1016\/j.heliyon.2024.e35953_bib50","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.clinbiochem.2011.08.1136","article-title":"Role of ischemia-modified albumin and total homocysteine in estimating symptomatic lacunar infarction in type 2 diabetic patients","volume":"44","author":"Ma","year":"2011","journal-title":"Clin. Biochem."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e35953_bib51","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/IAE.0b013e3181ed8cd1","article-title":"The relationship between diabetic retinopathy and serum levels of ischemia-modified albumin and malondialdehyde","volume":"31","author":"Turk","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.heliyon.2024.e35953_bib52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4137\/BMI.S9060","article-title":"Evaluation of ischemia-modified albumin and C-reactive protein in type 2 diabetics with and without ketosis","volume":"7","author":"Ma","year":"2012","journal-title":"Biomark. Insights"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e35953_bib53","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s12020-012-9652-9","article-title":"Increased serum levels of ischemia-modified albumin and C-reactive protein in type 1 diabetes patients with ketoacidosis","volume":"42","author":"Ma","year":"2012","journal-title":"Endocrine"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e35953_bib54","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3109\/09513590.2012.683069","article-title":"Evaluation of serum ischemia-modified albumin levels in pregnant women with and without gestational diabetes mellitus","volume":"28","author":"Ma","year":"2012","journal-title":"Gynecol. Endocrinol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e35953_bib55","first-page":"275","article-title":"Association of ischemia modified albumin in terms of hypoxic risk with carbonylated protein, glycosylated hemoglobin and plasma insulin in type 2 diabetes mellitus","volume":"9","author":"Dayanand","year":"2013","journal-title":"Int. J. Biotechnol. Biochem."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e35953_bib56","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3109\/00365513.2013.846477","article-title":"Total antioxidant status and markers of oxidative stress in subjects with normal or impaired glucose regulation (IFG, IGT) in diabetic patients","volume":"73","author":"Korkmaz","year":"2013","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"S3","key":"10.1016\/j.heliyon.2024.e35953_bib57","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s13410-013-0185-4","article-title":"Oxidant and antioxidant parameters in prediabetes and diabetes","volume":"35","author":"Erdem","year":"2014","journal-title":"Int. J. Diabetes Dev. Ctries."},{"key":"10.1016\/j.heliyon.2024.e35953_bib58","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/820853","article-title":"The association between diabetic retinopathy and levels of ischemia-modified albumin, total thiol, total antioxidant capacity, and total oxidative stress in serum and aqueous humor","volume":"2014","author":"Kirboga","year":"2014","journal-title":"J Ophthalmol"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35953_bib59","first-page":"18","article-title":"The relationship between ischemia modified albumin and lipids in type 2 Egyptian diabetic patients","volume":"8","author":"Refaat","year":"2014","journal-title":"Adv. Biol. Res."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e35953_bib60","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1038\/eye.2015.177","article-title":"Associations of FPG, A1C and disease duration with protein markers of oxidative damage and antioxidative defense in type 2 diabetes and diabetic retinopathy","volume":"29","author":"Reddy","year":"2015","journal-title":"Eye"},{"key":"10.1016\/j.heliyon.2024.e35953_bib61","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4137\/BMI.S39053","article-title":"Evaluation of ischemia-modified albumin, malondialdehyde, and advanced oxidative protein products as markers of vascular injury in diabetic nephropathy","volume":"11","author":"Ahmad","year":"2016","journal-title":"Biomark. Insights"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35953_bib62","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/00365513.2015.1092048","article-title":"High predictive ability of glycated hemoglobin on comparison with oxidative stress markers in assessment of chronic vascular complications in type 2 diabetes mellitus","volume":"76","author":"D'Souza","year":"2016","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e35953_bib63","first-page":"198","article-title":"Increased oxidative stress in diabetic nephropathy and its relationship with soluble Klotho levels","volume":"20","author":"Inci","year":"2016","journal-title":"Hippokratia"},{"key":"10.1016\/j.heliyon.2024.e35953_bib64","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4370490","article-title":"Xanthine oxidase activity in type 2 diabetes mellitus patients with and without diabetic peripheral neuropathy","volume":"2016","author":"Miric","year":"2016","journal-title":"J. Diabetes Res."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35953_bib65","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3906\/sag-1406-38","article-title":"Investigation of ischemia-modified albumin levels and some atherosclerosis-related serum parameters in patients with diabetic foot","volume":"46","author":"Muhtaroglu","year":"2016","journal-title":"Turk. J. Med. Sci."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e35953_bib66","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.amjms.2017.06.017","article-title":"Ischemia modified albumin test to detect early diabetic complications","volume":"354","author":"Ghosh","year":"2017","journal-title":"Am. J. Med. Sci."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e35953_bib67","article-title":"The level of ischemic modified albumin (IMA) as risk marker for cardio vascular disease (CVD) among some diabetic patients (type II) in khartoum state -Sudan","volume":"12","author":"Sadik","year":"2017","journal-title":"Sudan Journal of Medical Sciences"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e35953_bib68","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1177\/0003319717740781","article-title":"Association of Endocan, ischemia-modified albumin, and hsCRP levels with endothelial dysfunction in type 2 diabetes mellitus","volume":"69","author":"Balamir","year":"2018","journal-title":"Angiology"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e35953_bib69","first-page":"145","article-title":"Ischemia modified albumin levels in patients with diabetic nephropathy","volume":"22","author":"Bhaskhar","year":"2018","journal-title":"The Turkish Journal of Endocrinology and Metabolism"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e35953_bib70","doi-asserted-by":"crossref","DOI":"10.5958\/0976-5506.2018.00008.6","article-title":"Correlation of atherogenic indices and IMA with glycaemic control in diabetic patients with and without dyslipidemia","volume":"9","author":"Sudha","year":"2018","journal-title":"Indian Journal of Public Health Research & Development"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e35953_bib71","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2174\/1386207322666191008214919","article-title":"Role of ischemia modified albumin serum levels as an oxidative stress marker in children with diabetic ketoacidosis","volume":"22","author":"Yazici","year":"2019","journal-title":"Comb. Chem. High Throughput Screen."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e35953_bib72","doi-asserted-by":"crossref","first-page":"328","DOI":"10.5603\/DK.2020.0039","article-title":"The association of oxidative stress with serum irisin and betatrophin in pregnant women with gestational diabetes mellitus","volume":"9","author":"Beyazit","year":"2020","journal-title":"Clin. Diabetol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e35953_bib73","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.2174\/1871530320666200503052226","article-title":"Elevated serum levels of ischemia modified albumin and malondialdehyde are related to atherogenic index of plasma in a cohort of prediabetes","volume":"20","author":"El-Eshmawy","year":"2020","journal-title":"Endocr., Metab. Immune Disord.: Drug Targets"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e35953_bib74","first-page":"241","article-title":"Serum ischemia-modified albumin, fibrinogen, high sensitivity C- reactive proteins in type-2 diabetes mellitus without hypertension and diabetes mellitus with hypertension: a case-control study","volume":"9","author":"Sushith","year":"2020","journal-title":"Rep Biochem Mol Biol"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e35953_bib75","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14589","article-title":"An evaluation of ischemia-modified albumin levels in the development of diabetic foot ulcer","volume":"75","author":"Alay","year":"2021","journal-title":"Int. J. Clin. Pract."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e35953_bib76","first-page":"161","article-title":"Ischemia modified albumin levels in diabetes mellitus patients with and without diabetic retinopathy","volume":"16","author":"Chaudhry","year":"2021","journal-title":"J Islam Int Med Coll"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e35953_bib77","first-page":"500","article-title":"The role of protein oxidation in the development of diabetic microvascular complications","volume":"8","author":"Mertoglu","year":"2021","journal-title":"North Clin Istanb"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e35953_bib78","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14830","article-title":"Is ischemia-modified albumin a biomarker in wagner classification in diabetic foot ulcers?","volume":"75","author":"Ozkan","year":"2021","journal-title":"Int. J. Clin. Pract."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e35953_bib79","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.21037\/apm-21-425","article-title":"The expression and prognostic value of ischemia modified albumin (IMA), red blood cell distribution width (RDW), and lipoprotein (LP) in patients with diabetes mellitus complicated with coronary heart disease","volume":"10","author":"Xiang","year":"2021","journal-title":"Ann. Palliat. Med."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e35953_bib80","first-page":"507","article-title":"Serum ischemia modified albumin and oxidative stress levels in patients with gestational diabetes mellitus","volume":"27","author":"Arslan","year":"2022","journal-title":"E. J. Med."},{"key":"10.1016\/j.heliyon.2024.e35953_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2022.846470","article-title":"Correlation of serum CysC, IMA, and LP-PLA2 levels with type 2 diabetes mellitus patients with lower extremity atherosclerotic occlusive disease","volume":"9","author":"Feng","year":"2022","journal-title":"Front Surg"},{"key":"10.1016\/j.heliyon.2024.e35953_bib82","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3661822","article-title":"Endothelial dysfunction and ischemia-modified albumin levels in males with diabetic and nondiabetic erectile dysfunction","volume":"2022","author":"Kurt","year":"2022","journal-title":"Dis. Markers"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e35953_bib83","doi-asserted-by":"crossref","first-page":"653","DOI":"10.4103\/MJBL.MJBL_190_22","article-title":"Study the profile of some antioxidant markers in diabetic mellitus and non-diabetic patients with cardiovascular disease","volume":"19","author":"Zainal","year":"2022","journal-title":"Med J Babylon"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e35953_bib84","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/1467-8721.ep10768783","article-title":"Statistical power analysis","volume":"1","author":"Cohen","year":"1992","journal-title":"Curr. Dir. Psychol. Sci."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e35953_bib85","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1136\/hrt.2005.078089","article-title":"Effects of balloon occlusion during percutaneous coronary intervention on circulating Ischemia Modified Albumin and transmyocardial lactate extraction","volume":"92","author":"Sinha","year":"2006","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e35953_bib86","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0736-4679(00)00255-9","article-title":"A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report","volume":"19","author":"Bar-Or","year":"2000","journal-title":"J. Emerg. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e35953_bib87","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1179\/1351000213Y.0000000083","article-title":"Oxidative stress and ischemia-modified albumin in chronic ischemic heart failure","volume":"19","author":"Ellidag","year":"2014","journal-title":"Redox Rep."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e35953_bib88","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/ggi.12361","article-title":"Ischemia-modified albumin and advanced oxidation protein products as potential biomarkers of protein oxidation in Alzheimer's disease","volume":"15","author":"Altunoglu","year":"2015","journal-title":"Geriatr. Gerontol. Int."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e35953_bib89","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ejogrb.2013.06.037","article-title":"Ischemia-modified albumin in pregnancy","volume":"170","author":"Rossi","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e35953_bib90","article-title":"The evaluation of oxidative stress parameters in breast and colon cancer","volume":"100","author":"Kundaktepe","year":"2021","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.heliyon.2024.e35953_bib91","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2147\/CIA.S158513","article-title":"Oxidative stress, aging, and diseases","volume":"13","author":"Liguori","year":"2018","journal-title":"Clin. Interv. Aging"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e35953_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/cells11030552","article-title":"Oxidative stress in human pathology and aging: molecular mechanisms and perspectives","volume":"11","author":"Hajam","year":"2022","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e35953_bib93","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.2337\/dc18-0695","article-title":"Prognostic values of inflammatory and redox status biomarkers on the risk of major lower-extremity artery disease in individuals with type 2 diabetes","volume":"41","author":"Nativel","year":"2018","journal-title":"Diabetes Care"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024119846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024119846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T22:45:16Z","timestamp":1773182716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024119846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":93,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2405844024119846"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e35953","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review and meta-analysis of ischemia-modified albumin in diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e35953","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e35953"}}